Test filters

News

In the media

Press releases

Publications

Scientific articles

Statements

Stories

Videos

Viewpoints

Press releases

1 Jul 2025

Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment

Publications

27 Jun 2025

2024 DNDi Financial Report

Scientific articles

26 Jun 2025

Validated LC-MS/MS method for quantifying the antiparasitic nitroimidazole DNDI-0690 in preclinical target site PK/PD studies

Biomedical Chromatography

In the media

17 Jun 2025

Can the use of AI in the pharmaceutical sector deliver new medicines, not new risks?

BMJ Innovations

In the media

17 Jun 2025

Serum Institute signs MoU with DNDi to develop dengue treatment candidate

Business Standard

In the media

17 Jun 2025

‘Timely’ alliance to develop effective dengue treatment

The Sun

In the media

14 Jun 2025

Serum Institute to conduct Brazilian trials of late-stage dengue candidate with DNDi

ET Pharma

In the media

14 Jun 2025

Serum, DNDi to develop affordable dengue treatment

Hindustan Times

In the media

14 Jun 2025

SII, DNDi partner for expanding human trials for dengue treatment

The Hindu

In the media

13 Jun 2025

Serum, DNDi join hands to fast-track development of new treatment for dengue

Press Trust of India

Press releases

13 Jun 2025

Serum Institute of India signs a memorandum of understanding (MoU) with DNDi to advance the development of a new treatment for dengue in low- and middle-income countries

Press Releases Translations

13 Jun 2025

DNDi와 소외질환 치료제 개발 공동 연구 나선다

Press releases

13 Jun 2025

K-MEDI and DNDi have initiated collaborative R&D to develop a treatment for neglected diseases

In the media

10 Jun 2025

Sudanese doctors on mission to rebuild Mycetoma Research Centre

France 24

In the media

8 Jun 2025

Uncovering Turkana’s Silent Plague: The Gruesome Disease Crippling a Region

The Kenyan Historian

In the media

8 Jun 2025

Kenya: le mycétome, une maladie endémique pourtant encore négligée

TV5Monde

International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Thailand’s Government Pharmaceutical Organization (GPO) partners with DNDi and Pharco to register an effective and affordable hepatitis C treatment

2024 DNDi Financial Report

Validated LC-MS/MS method for quantifying the antiparasitic nitroimidazole DNDI-0690 in preclinical target site PK/PD studies

Can the use of AI in the pharmaceutical sector deliver new medicines, not new risks?

Serum Institute signs MoU with DNDi to develop dengue treatment candidate

‘Timely’ alliance to develop effective dengue treatment

Serum Institute to conduct Brazilian trials of late-stage dengue candidate with DNDi

Serum, DNDi to develop affordable dengue treatment

SII, DNDi partner for expanding human trials for dengue treatment

Serum, DNDi join hands to fast-track development of new treatment for dengue

Serum Institute of India signs a memorandum of understanding (MoU) with DNDi to advance the development of a new treatment for dengue in low- and middle-income countries

DNDi와 소외질환 치료제 개발 공동 연구 나선다

K-MEDI and DNDi have initiated collaborative R&D to develop a treatment for neglected diseases

Sudanese doctors on mission to rebuild Mycetoma Research Centre

Uncovering Turkana’s Silent Plague: The Gruesome Disease Crippling a Region

Kenya: le mycétome, une maladie endémique pourtant encore négligée

Learn more

Get in touch

Support us

Work with us